[go: up one dir, main page]

NO900276D0 - Nye benzopyranderivater, deres fremstilling og anvendelsei farmasoeytiske preparater. - Google Patents

Nye benzopyranderivater, deres fremstilling og anvendelsei farmasoeytiske preparater.

Info

Publication number
NO900276D0
NO900276D0 NO900276A NO900276A NO900276D0 NO 900276 D0 NO900276 D0 NO 900276D0 NO 900276 A NO900276 A NO 900276A NO 900276 A NO900276 A NO 900276A NO 900276 D0 NO900276 D0 NO 900276D0
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical preparations
new
benzopyrane derivatives
derivatives
Prior art date
Application number
NO900276A
Other languages
English (en)
Other versions
NO900276L (no
Inventor
Michel Barreau
Jean-Claude Hardy
Jean-Paul Martin
Christian Renault
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO900276D0 publication Critical patent/NO900276D0/no
Publication of NO900276L publication Critical patent/NO900276L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO90900276A 1989-01-20 1990-01-19 Nye benzopyranderivater, deres fremstilling og anvendelsei farmasoeytiske preparater. NO900276L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8900657A FR2642069B1 (fr) 1989-01-20 1989-01-20 Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO900276D0 true NO900276D0 (no) 1990-01-19
NO900276L NO900276L (no) 1990-07-23

Family

ID=9377904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900276A NO900276L (no) 1989-01-20 1990-01-19 Nye benzopyranderivater, deres fremstilling og anvendelsei farmasoeytiske preparater.

Country Status (12)

Country Link
US (1) US5025013A (no)
EP (1) EP0379441A1 (no)
JP (1) JPH02233675A (no)
KR (1) KR900011760A (no)
AU (1) AU622265B2 (no)
CA (1) CA2008157A1 (no)
FI (1) FI900313A7 (no)
FR (1) FR2642069B1 (no)
HU (1) HUT58078A (no)
NO (1) NO900276L (no)
PT (1) PT92916A (no)
ZA (1) ZA90387B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
FR2705674B1 (fr) * 1993-05-26 1996-01-05 Smithkline Beecham Labo Pharma Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments.
WO1994027967A1 (en) * 1993-05-26 1994-12-08 Smithkline Beecham Laboratoires Pharmaceutiques Novel compounds
CZ180898A3 (cs) * 1995-12-15 1999-05-12 Pfizer Inc. Způsob a meziprodukty pro výrobu 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidinu
DE10000739A1 (de) * 2000-01-11 2001-07-12 Merck Patent Gmbh Piperidin- und Piperazinderivate
ATE348808T1 (de) 2000-03-06 2007-01-15 Acadia Pharm Inc Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
WO2001081308A2 (en) * 2000-04-20 2001-11-01 Nps Allelix Corp. Aminopiperidines for use as glyt-1 inhibitors
CN101050215A (zh) * 2001-12-28 2007-10-10 阿卡蒂亚药品公司 作为单胺受体调节剂的螺氮杂环化合物
US7253186B2 (en) * 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
BR0312217A (pt) * 2002-06-24 2005-05-10 Acadia Pharm Inc Compostos, métodos de inibição da atividade/ativação de um receptor monoaminérgico e método de tratamento de condição doentia associada a um receptor de monoaminergético
US7538222B2 (en) * 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
MY139563A (en) * 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues
EP1587789B1 (en) * 2003-01-16 2008-09-03 Acadia Pharmaceuticals Inc. Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
HRP20050993A2 (en) * 2003-06-17 2006-03-31 Pfizer Inc. N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
US7820695B2 (en) * 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) * 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US7790899B2 (en) * 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
US7868176B2 (en) * 2004-09-27 2011-01-11 Acadia Pharmaceuticals, Inc. Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation
AU2008228833B9 (en) 2007-03-19 2013-10-24 Acadia Pharmaceuticals Inc. Combinations of 5-HT2A inverse agonists and antagonists with antipsychotics
EP2155716A2 (en) * 2007-05-09 2010-02-24 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
HUE037639T2 (hu) * 2007-09-21 2018-09-28 Acadia Pharm Inc Pimavanszerin együttes beadása más szerekkel
JP6850282B2 (ja) 2015-07-20 2021-03-31 アカディア ファーマシューティカルズ インコーポレーテッド Ｎ−（４−フルオロベンジル）−ｎ−（１−メチルピペリジン−４−イル）−ｎ’−（４−（２−メチルプロピルオキシ）フェニルメチル）カルバミドならびにその酒石酸塩および多形形態ｃを調製する方法
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
EP3558311A1 (en) 2016-12-20 2019-10-30 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
WO2018200977A1 (en) 2017-04-28 2018-11-01 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
US20210077479A1 (en) 2017-08-30 2021-03-18 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3300004A1 (de) * 1983-01-03 1984-07-12 Bayer Ag, 5090 Leverkusen Substituierte 4-aminomethylenchromane bzw. -chromene, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
FR2618437B1 (fr) * 1987-07-23 1989-11-17 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les medicaments qui les contiennent
EP0322361A3 (de) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen

Also Published As

Publication number Publication date
CA2008157A1 (fr) 1990-07-20
HUT58078A (en) 1992-01-28
FI900313A7 (fi) 1990-07-21
JPH02233675A (ja) 1990-09-17
HU900206D0 (en) 1990-03-28
AU622265B2 (en) 1992-04-02
AU4858490A (en) 1990-07-26
EP0379441A1 (fr) 1990-07-25
PT92916A (pt) 1990-07-31
ZA90387B (en) 1991-11-27
FI900313A0 (fi) 1990-01-19
KR900011760A (ko) 1990-08-02
FR2642069A1 (fr) 1990-07-27
US5025013A (en) 1991-06-18
FR2642069B1 (fr) 1991-04-12
NO900276L (no) 1990-07-23

Similar Documents

Publication Publication Date Title
NO900276L (no) Nye benzopyranderivater, deres fremstilling og anvendelsei farmasoeytiske preparater.
NO934146D0 (no) Nye derivater av tiopyranopyrrol, deres fremstilling og farmas!ytiske preparater inneholdende forbindelsene
DK267489D0 (da) 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO905354D0 (no) Nye glykopolypeptidderivater og fremgangsmaate for deres fremstilling.
DK56086D0 (da) 11beta-phenylgonaner, deres fremstilling og farmaceutiske praeparaterindeholdende dem
NO884625D0 (no) N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel.
DK143588A (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
NO900577D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DK166590D0 (da) Substituerede allylaminderivater, deres fremstilling og anvendelse som laegemidler
DK366888D0 (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
NO901396L (no) Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer.
DK183585D0 (da) Iminothiazolidinderivater, deres fremstilling og farmaceutiske praeparater deraf
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK648389D0 (da) Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler
NO901239L (no) Nye platinakompleksderivater, deres fremstilling og deresanvendelse i farmasoeytiske preparater.
DK501888D0 (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
DK454588D0 (da) Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler
FI900312A7 (fi) Uudet bentsopyraanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO893291D0 (no) Fremgangsmaate for fremstilling av nye benzasolderivater og farmasoeytiske preparater derav.